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Abstract
Background: As increasing numbers of older people are listed for solid organ transplantation, there is an urgent need to
better understand how aging modifies alloimmune responses. Here, we investigated whether aging impairs the ability of
donor dendritic cells or recipient immunity to prime alloimmune responses to organ transplantation.
Principal Findings: Using murine experimental models, we found that aging impaired the host environment to expand and
activate antigen specific CD8
+ T cells. Additionally, aging impaired the ability of polyclonal T cells to induce acute allograft
rejection. However, the alloimmune priming capability of donor dendritic cells was preserved with aging.
Conclusion: Aging impairs recipient responses, both T cell intrinsic and extrinsic, in response to organ transplantation.
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Introduction
During the last decade, increasing numbers of people over 65
years of age are currently waiting for kidney transplants [1,2].
Since the number of older people in our society will continue to
grow and as many end stage organ disorders are associated with
increased age, it is likely that an even larger number of older
patients will receive solid and cellular transplants in the coming
years [2,3].
Clinical studies have indicated that older people have a reduced
immune response to infections as well as an impaired ability to
reject organ allografts [4–11]. Overall, it is not clear how aging
alters the response to organ transplantation. Some experimental
reports have indicated that reduced alloimmune responses may be
due to declining cellular immunity [12–14], while other reports
have shown that increasing donor age can negatively impact
allograft survival [15]. In contrast to these reports, there is
evidence that aging is associated with increased chronic rejection
[16]. Hence, aging may impact alloimunity via multiple effects,
although it is unclear whether altered cellular alloimmunity with
aging is due to impaired priming by dendritic cells (DCs) or due to
defective intrinsic T cell function.
Donor DCs, recipient DCs and T cells are some of the critical
cellular mediators of acute allograft rejection as defects in these
cells can significantly impair the ability of recipients to reject organ
transplants [17–19]. However, the impact of aging on the effect on
each of these cells in the setting of allotransplantation is not fully
elucidated and it is not clear if declining cellular alloimmunity with
aging is due to impaired priming by DCs or defective recipient
factors intrinsic or extrinsic to the T cell. Hence, the goal of the
present study was to determine whether aging impairs alloimmune
priming function of donor DCs, recipient DCs or T cell intrinsic
alloimmune responses. We provide evidence that factors both
intrinsic and extrinsic to recipient T cells are defective with aging
in response to skin transplantation, however aging does not impair
the ability of donor DCs to prime alloimmune responses in our
experimental systems.
Results
Aged donor bone marrow derived DCs (BMDCs) exhibit
similar alloimmune priming capabilities as compared to
young counterparts
Prior work has indicated that donor DCs are one of the main
cellular activators of acute allograft rejection [20]. Hence, we
examined the effect of age on the ability of BMDCs to stimulate
allo-reactive splenocytes. Young C57BL/6 mice were immunized
with young CBA spleen cells. Two weeks later, recipient spleen
cells were harvested and stimulated ex vivo with irradiated aged
(20–22 months of age) or young (2–4 months of age) CBA
BMDCs. The results show that aged BMDCs induced similar
production of IFN-c in allo-reactive spleen cells as compared to
young BMDCs (Figure 1A). These results are consistent with prior
work that demonstrated that aged and young allogeneic BMDCs
were equally able to activate naı ¨ve T cells in vitro [21].
To examine the role of aging on the in vivo priming capabilities
of allogeneic BMDCs, aged or young CBA BMDCs were injected
into young C57BL/6 mice. Two weeks later the recipient spleens
were harvested and stimulated ex vivo with young, irradiated CBA
spleen cells. The results demonstrate that aged donor BMDCs
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e4097exhibit a similar in vivo priming ability, as measured by IFN-c
produced by recipient spleen cells, compared to young counter-
parts (Figure 1B).
Splenic APCs and DCs exhibit a preserved ability to prime
allogeneic T cells with aging
In the above experiments, we employed BMDCs, which were
expanded ex vivo with GM-CSF. As this may have masked a defect
with aging, we next performed experiments with antigen
presenting cells (APCs) and DCs that were purified directly from
mice, without any further ex vivo expansion. Splenic APCs and
DCs purified from aged (18–20 months of age) mice exhibited a
similar ability to induce allogeneic T cell proliferation and IFN-c
production in vitro as compared to young cells (Figure 2A).
Furthermore, DCs purified from aged mice exhibited a similar
alloimmune priming response in vivo (Figure 2B) as compared to
young cells. Additionally, aged DCs manifested similar surface
expression of MHC class II, CD40, CD54 and CD86 at rest and
after culture with allogeneic T cells as compared to young DCs
(data not shown).
Graft originating APCs exhibit a similar ability to prime
allogeneic T cell responses and induce a similar tempo of
allograft rejection with aging
To investigate whether aging influenced the ability of graft
originating, donor APCs to prime alloimmune responses, aged or
young C57BL/6 allografts were transplanted onto young CBA
recipients. In this experimental design, all the recipient DCs and T
cells are young and the experimental variable is the age of the
donor APC. Two weeks later, recipient spleen cells were harvested
and stimulated ex vivo with irradiated donor (i.e., C57BL/6) spleen
cells. The results show that aged allografts induced similar IFN-c
responses in young recipients as compared to young recipients
transplanted with a young allograft (Figure 3A). Finally, aged
C57BL/6 allografts underwent a similar tempo of allograft
rejection when transplanted onto young CBA recipients as
compared to young allografts transplanted onto young recipients
(Figure 3B). In sum, these data indicate that aging does not impair
the ability of donor, graft originating APCs to prime T cell
responses in our experimental systems.
The aged host environment impairs the activation and
expansion of transplant specific CD8
+ T cells
We next examined the impact of aging on recipient APCs to
prime and expand alloreactive T cells. Hence, aged or young
CD45.2
+, Thy1.2
+ C57BL/6 mice were adoptively transferred
with young naı ¨ve (CD44
lo, CD62L
hi) CD45.1
+ TCR transgenic T
cells that are reactive to the SINFEKL OVA257–264 peptide
presented by MHC class I (cells denoted as OTI) and young naı ¨ve
Thy1.1
+ transgenic T cells that are reactive to OVA323–339 peptide
presented by MHC class II (cells denoted as OTII). Two days
later, aged or young adoptively transferred mice received a young
B6 OVA-expressing skin transplant (Act-mOVA). These mice
express a membrane-bound form of OVA that is expressed under
the control of b-actin promoter. This is an established minor-
mismatched transplant model, which allows one to track the fate of
graft-specific T cells in vivo [22]. Thus, in this experimental design
the variable is the recipient age, which contains recipient APCs.
At various time points post transplantation, spleen cells were
harvested and the cytokine function and expansion of young OTI
(CD8
+) and OTII (CD4
+) T cells in either aged or young recipients
were measured. We found that the peak expansion of young
antigen specific CD8
+T cells was reduced in an aged environment
as compared to a young environment (Figure 4). However, young
antigen specific CD8
+T cells produced similar cytokine responses
for IFN-c, IL-2 and TNFa regardless of the age of the host
environment (Figure 5A). Nevertheless, the activation status
(measured by the up-regulation of CD27 and down-regulation of
CD62L) of antigen specific CD8
+ T cells was higher in young hosts
than in aged hosts (Figure 5B). We noted that CD4
+ T cell
responses were generally a log-fold lower than CD8
+ T cell
responses in this experimental model and with similar responses in
either an aged or young environment (data not shown). These data
indicate that aging impairs the recipient host environment
(containing APCs) to activate and expand antigen specific CD8
+
T cell responses in vivo, although the aged host environment
allows effective cytokine responses in these T cells.
The above results indicate that factors within the aged host
extrinsic to the T cell impair the expansion of antigen specific
CD8
+ T cells. To examine if aging impaired the ability of DCs to
process and present cognate peptides to antigen specific CD8
+ T
Figure 1. Aged BMDCs exhibit a similar alloimmune priming ability as compared to young BMDCs. A: Young C57BL/6 mice were
immunized (via i.p. injection) with 1610
7 young CBA spleen cells. After two weeks, recipient spleen cells were harvested and cultured ex vivo
overnight with increasing numbers of either aged or young irradiated CBA BMDCs and IFN-c responses measured (ELISPOT). B: Aged or young CBA
BMDCs were i.p. injected into young C57BL/6 mice. Two weeks later, recipient spleen cells were harvested and cultured ex vivo overnight with young
irradiated CBA spleen cells. IFN-c responses measured via ELISPOT. Similar results were obtained when the re-stimulating irradiated donor spleen cells
were aged (data not shown).
doi:10.1371/journal.pone.0004097.g001
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activate OTI CD8
+ T cells in vitro. Our results demonstrate that
aged splenic DCs, cultured with OVA peptides, were able to
induce a similar degree of proliferation in OTI CD8
+ T cells in
comparison to young splenic DCs (Figure 6A). We next examined
the ability of aged and young splenic DCs, which were pulsed with
OVA peptides and then adoptively transferred into young
syngeneic recipients, to expand and activate OTI CD8
+ T cells
in vivo. The results demonstrate that OTI T CD8
+ T cells
transferred with aged splenic DCs into young recipients exhibited
a similar expansion and inflammatory cytokine response as
compared to young OTI CD8
+ T cells transferred with young
splenic DCs into young recipients (Figure 6B–C).
Aging impairs T cell responses to allotransplantation
Our results above indicate that aging does not impair the ability
of either donor or recipient DCs to prime transplant specific T cell
responses. We next examined if aging impairs T cell alloimmune
responses, by adoptively transferred magnetically purified aged or
young T cells into young T cell deficient mice, which received a
skin allograft two days earlier. We found that young recipients that
received aged T cells manifested a slightly delayed time to allograft
rejection as compared to young recipients that received young T
cells (Figure 7A).
To examine whether aging affects recipient T cell responses
primed by young, donor APCs in vivo, young or aged CBA recipients
were transplanted with a young C57BL/6 allograft. Two weeks post
transplantation, recipient T cells were enriched and CD4
+ Tc e l l s
purified via magnetic sorting. The purified CD4
+ Tc e l l s ,w h i c hw e
confirmed by flow cytometry were devoid of recipient APCs (data
not shown), were subsequently stimulated ex vivo with irradiated
donor spleen cells. The results show that aging significantly impaired
the ability of CD4
+ T cells to respond to young donor APCs as
compared to young CD4
+ T cells (Figure 7B).
Figure 2. Aged splenic DCs and APCs exhibit a similar ability to prime allogeneic T cell responses both in vitro and in vivo. A: Splenic
APCs and CD11c
+ DCs, purified from aged or young CBA mice, were cultured with C57BL/6 T cells and cellular proliferation and IFN-c measured.
Similar results were noted in two independent experiments and with an alternate donor (C57BL/6) and recipient T cell (BALB/C) combination. B: Aged
or young splenic CBA DCs were injected into C57BL/6 mice. 10 days later spleens were harvested from the groups and cultured with irradiated CBA
spleen cells, and cellular proliferation and IFN-c measured. The change from T cells from mice that were not immunized is shown. There were no
significant differences noted between mice injected with either young or aged allogeneic DCs. Representative data from one experiment, which was
repeated with consistent results.
doi:10.1371/journal.pone.0004097.g002
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that aged polyclonal T cells did not upregulate certain T cell
activation markers, CD25 and CD28, to the same degree as young
polyclonal T cells, although the upregulation of other activation
markers, e.g., ICOS, was preserved with aging (Figure 7C). Prior
work has shown that aged T cells manifest impaired IL-2 and IFN-
c responses in this assay [21]. In summary, the above data indicate
that aging impairs T cells to respond to allostimulation.
Discussion
Aging has been associated with lower frequencies of acute
allograft rejection, yet it has not been clear if such a phenotype is
due to impaired donor or recipient APC priming of alloreactive T
cells. Our study has provided evidence that aging impairs the
ability of the recipient host environment, both intrinsic and
extrinsic to the T cell, to respond to skin transplants. However, the
alloimmune priming capabilities of donor APCs are preserved
with aging in our experimental systems. Other work has indicated
that aging augments immune priming by donor DCs [23] and our
study does not exclude that aging may play important roles of the
function of donor DCs, especially when DCs originate from
vascularized allografts. Overall, our study indicates that aging
impairs recipient immune responses to allostransplantation,
whereas donor APC and DC responses remain preserved in our
experimental systems.
We determined that aging also impaired the ability of the
recipient host environment, extrinsic to the T cell, to expand and
activate antigen specific naı ¨ve CD8
+ T cells in response to skin
transplantation (Figure 2 and 3B). We directly examined whether
aging led to a defective ability of recipient splenic DCs to prime
and activate antigen specific T cells. In our experimental system,
the antigen in this case, an OVA peptide, was also a transplant
antigen. However, we did not discern that aged splenic DCs
exhibited a defective ability to expand and activate antigen specific
CD8
+ T cells as compared to young DCs. It is not clear what
factors within the aged host impair the ability of antigen specific
CD8
+ T cells to expand, although possibilities include heightened
BCL-2 and type I interferon levels. This is because a prior study,
which employed non-transplant experimental models, found that
the aged host environment impaired the turnover of memory
CD44
hi CD8
+ T cells via heightened BCL-2 expression and higher
type I interferon levels [24]. Future studies are warranted to
determine the factors within the aged host environment that
impair the expansion of antigen-specific, naı ¨ve CD8
+ T cells.
In conclusion, our study provides evidence that aging impairs
recipient factors, both intrinsic and extrinsic to the T cell during
transplantation. This information may provide a foundation for
further mechanistic studies investigating how aging modifies
alloimmunity, as well as translational studies that investigate how
older people respond differently to solid organ allografts.
Materials and Methods
Mice
Aged (18–22 months) and young (2–4 months) CBA (H2
k)a n d
C57BL/6 (H2
b) mice were purchased from the NIA rodent facility.
B6.129P2-Tcrb
tm1MomTcrd
tm1Mom (designated as T cell deficient
mice), BALB/c and B6 Act-mOVA mice were purchased from the
Jackson Laboratories, Bar Harbor, ME. B6.CD45.1
+ OT1 and
B6.Thy1.1
+ OTII mice were generously provided by Dr. Richard
Flavell and Dr. Lauren Cohn, respectively (Yale University). Yale
University IACUC approved the use of animals in this study. All
micewere kept inpathogen free conditions. Noanimals were used in
the study if they had evidence of skin lesions, weight loss or
lymphadenopathy. Additionally, sentinel mice were regularly tested
Figure 3. Aging does not impair the ability of graft originating APCs to prime alloimmunity. C: Young CBA recipients received either
aged or young C57BL/6 skin allografts. Two weeks after transplantation, recipient spleens were removed and then restimulated overnight in the
presence of irradiated donor spleen cells. (No differences were noted if aged or young donor irradiated stimulators were used, data not shown). D:
Young CBA recipients were transplanted with either an aged or young C57BL/6 skin allograft and the time to rejection was monitored. Young
recipients of aged allografts manifest similar rejection kinetics compared to young counterparts that received young allografts (p=0.5; Log rank).
doi:10.1371/journal.pone.0004097.g003
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murine pathogens in the serum, nasopharynx and the gastrointes-
tinal tract (pathogens tested included mouse hepatitis virus,
parvovirus, mycoplasma pneumonia, sendai virus, lymphocytic
choriomengitis virus, ectromelia virus, pneumonia virus and
epizootic diarrhea of infant mice).
Skin transplantation
Full-thickness trunk skin was transplanted from donor mice and
stapled on recipients as previously described [25]. Rejection was
defined as graft necrosis .90% of the graft area.
Cell purification, and in vitro T cell cultures
The generation of BMDCs has been described in our previous
work [26]. Splenic DCs were purified by positive selection (anti-
phycoerythrin-CD11c monoclonal antibody) using EasySep
(StemCell Technologies, Vancouver, BC, Canada). Splenic APCs
were purified by depleting spleen cells of T cells, using reagents
from EasySep. T cells were purified via negative magnetic
selection using EasySep reagents. To perform the primary mixed
lymphocyte reaction (MLR), 1610
5 purified CBA T cells/well
were cultured with irradiated (28Gy) allogeneic C57BL/6 BMDCs
(1610
5/well), splenic DCs (1610
4/well), splenic APCs or whole
splenic cells (1610
5/well) and incubated in 96 well plates at 37uC
in a 5% CO2 incubator for 4 days. To perform ex vivo analysis from
immunized mice, T cells were cultured with the indicated
irradiated donor cells for 2 days. For ex vivo analysis from
transplanted mice, T cells were cultured ex vivo with the indicated
number of irradiated donor cells ,24 h. For in vitro culture of OTI
CD8
+ T cells, 1610
5 purified OTI T cells/well were cultured with
2610
4/well irradiated (30Gy) aged or young splenic DCs in the
presence of OVA peptide at the indicated dose for 72 h.
Thymidine incorporation assay was used to measure cellular
proliferation according to our prior work [27].
ELISPOT and ELISA
ELISPOT analysis was performed as per our previously
published work [26]. ELISA of culture supernatants was
performed using reagents from BD Biosciences (San Diego, CA),
according to manufacturer’s instructions.
Figure 4. Recipient age impairs the expansion of transplant reactive CD8
+ T cells. C57BL/6 aged and young CD45.2
+, Thy1.2
+ mice were
adoptively transferred with 5610
5 CD45.1
+, OTI T cells 2 days prior to receiving a B6.Act-mOVA skin transplant. A: At various points after
transplantation, recipient spleen cells were harvested and the number of OTI T cells or OTI T cells that produced IFN-c calculated. Expansion of
transplant/antigen specific T cells was reduced in an aged environment as compared to a young environment. (*P,0.02; T test at day +7 post
transplantation). Representative data of three independent experiments with N=2–3/experiment. B: Representative flow cytometric dot plots are
shown at day +7 post transplantation in young and aged mice. A representative, non-transplanted recipient that received OTI T cells is shown. The
transferred cells (CD45.1
+, CD8
+) are shown in the rectangle. Representative data of three independent experiments with N=2–3/experiment.
doi:10.1371/journal.pone.0004097.g004
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+ T cells produced similar cytokine profiles but impaired activation in aged transplant recipients
as compared to young recipients. A: Representative flow cytometric plots on day +7 post transplantation are shown along with isotype controls
(IgG2b for IFNc, IgG1 for IL-2 and TNFa). Young antigen specific CD8
+ T cells produced similar amounts of TNFa, IL-2 and IFN-c during ex vivo culture
with OVA peptide regardless of the age of the recipient environment (cytokines were not produced if peptide was not added, data not shown).
Proportions are shown in right upper quadrant. Note, that cytokines were not detected in either aged or young mice that were adoptively transferred
but did not receive an OVA expressing skin transplant (data not shown). Similar results were noted at day +14 post transplantation (data not shown).
Flow cytometric plots are gated on CD45.1
+ cells. N=3/group, representative data from three independent experiments with consistent results. B:
Representative flow cytometric plots of adoptively transferred CD45.1
+, OTI young T cells on day +7 post transplantation. Young antigen specific
CD8
+ T cells upregulated CD27 and downregulated CD62L to a greater degree in young transplant recipients compared to antigen specific CD8
+ T
cells in aged transplant recipients.
doi:10.1371/journal.pone.0004097.g005
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PLoS ONE | www.plosone.org 7 January 2009 | Volume 4 | Issue 1 | e4097Figure 7. Aging impairs T cell alloimmune responses. A: Young C57BL/6 T cell deficient mice reconstituted with 5610
6 aged (20 mths)
syngeneic, polyclonal T cells rejected BALB/c skin allografts at a slower tempo than counterparts reconstituted with young (2–4 mths) T cells.
(*p=0.007; Log rank). B: Aged or young CBA recipients were transplanted with young C57BL/6 skin transplants. At two weeks post transplantation,
recipient spleen cells were harvested and CD4
+ T cells purified. The results demonstrate that aged CD4
+ T cells that were stimulated ex vivo with
irradiated donor spleen cells manifest impaired IFNc (*p,0.0001; T test) and IL-2 (**p,0.0001; T test) responses (ELISPOT) compared to young CD4
+ T
cells. N=3/group, representative data from two independent experiments with consistent results. C: Aged and young purified, polyclonal T cells were
stimulated with C57BL/6 BMDCs and the upregulation of indicated activation markers shown after 96 h of culture. N=3/group, representative data
three independent experiments with consistent results.
doi:10.1371/journal.pone.0004097.g007
Figure 6. Aged splenic DCs loaded with cognate peptide exhibit a similar ability to prime antigen specific CD8
+ T cells as compared
to young splenic DCs. A: Aged and young splenic DCs were cultured with OTI T cells in the presence of OVA peptide and proliferation measured.
Representative from one experiment, which was repeated with similar results. B: Young hosts (N=3/group) were adoptively transferred with young
CD45.1
+ OTI T cells and either young or aged splenic DCs that had been pulsed with OVA peptide (or irrelevant peptide, GP33, as a control). After 5
days, expansion of transferred young OTI T cells was assessed. Proportion of transferred T cells is shown in the box in each flow plot. Representative
data from one experiment, which was repeated with similar results. C: Same experiment as B except that cytokine production by the transferred OTI T
cells (gated on CD45.1
+ population) is measured by intracellular cytokine staining. Proportion % is shown in each flow plot.
doi:10.1371/journal.pone.0004097.g006
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5610
5 OTI (CD45.1
+) and 5610
5 OTII (Thy1.1
+) were
adoptively transferred via i.v. tail vein injection into either aged
or young syngeneic CD45.2
+, Thy1.2
+ C57BL/6 mice. Two days
after adoptive transfer, mice received a skin graft from a B6.Act-
mOVA donor. The absolute number of OTI/OTII T cells was
calculated by multiplying the proportion of positive cells by the
total number of splenocytes. Mice were immunized with 1610
7
BMDCs via i.p. injection. For immunization with allogeneic
splenic DCs, mice received 3610
5 splenic DCs via i.v. tail vein
injection. For adoptive transfer of syngeneic splenic DCs, pulsed
with OVA257–264 peptide, DCs were 1
st incubated overnight with
50 ng/ml LPS. The cells were then washed and pulsed with
10 g m/ml of OVA peptide for 2 h at 37uC and then washed three
times prior to adoptive transfer into young hosts. Splenic DCs
pulsed with an irrelevant peptide (GP33) acted as control. 5610
5
splenic DCs were transferred via i.v. tail vein injection along with
5610
5 CD45.1
+ OTI T cells. Five days later, spleen cells were
harvested from adoptively transferred mice for flow cytometric
analysis.
Cell sorting and flow cytometry
CD4, CD8, CD45.1, CD25, CD27, CD28, ICOS CD62L,
Thy1.1/1.2, CD45.1, IL-2, TNFa and IFN-c fluorescently labeled
monoclonal antibodies and isotype controls were purchased from
eBiosciences (San Diego, CA). Intracellular cytokine staining was
achieved by harvesting spleen cells post transplantation and
stimulating the cells ex-vivo with cognate peptide (for OTI and
OTII TCR transgenic T cells) in the presence of cell permeability
agents and golgi stop (eBiosciences). T cells were identified during
the MLR by staining with Thy1.2 fluorescently labeled monoclo-
nal antibody. All analysis was performed on a FACS CALIBUR
flow cytometer and analyzed with Flow Jo software.
Statistical analysis
Survival analysis between groups was calculated using the Log-
rank method. Comparison of means was performed using a 2-
tailed T-test and repeated measures using analysis of variance. All
results were generated using GraphPad prism software (San Diego,
CA). Statistical significance was considered a p value ,0.05.
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